Advancing pharmaceuticals and patient safety in Saudi Arabia: A 2030 vision initiative
Low-quality medicines deliver sub-optimal clinical outcomes and waste precious health resources. It is important to ensure that public funds are spent on healthcare technologies that meet national regulatory bodies such as the Saudi Food and Drug Authority (SFDA), quality standards for safety, effic...
Main Authors: | Tariq M. Alhawassi, Hatem A. Abuelizz, Mansour Almetwazi, Mansour A. Mahmoud, Ahmed Alghamdi, Yazed S. Alruthia, Nasser BinDhim, Khalid A. Alburikan, Yousif A. Asiri, Peter J. Pitts |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Saudi Pharmaceutical Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016417301780 |
Similar Items
-
The status of licensed pharmacy workforce in Saudi Arabia: a 2030 economic vision perspective
by: Yazed AlRuthia, et al.
Published: (2018-06-01) -
Factors associated with glycemic control in type 2 diabetic patients in Saudi Arabia
by: Mansour Almetwazi, et al.
Published: (2019-03-01) -
Pharmacy students’ satisfaction with Introductory Pharmacy Practice Experiences (IPPE) at community pharmacy: The case of Saudi Arabia
by: Mansour Almetwazi, et al.
Published: (2020-01-01) -
The Commonly Utilized Natural Products during the COVID-19 Pandemic in Saudi Arabia: A Cross-Sectional Online Survey
by: Sina M. AlNajrany, et al.
Published: (2021-04-01) -
How can Saudi Arabia reform its public hospital payment models? A narrative review
by: Yazed AlRuthia, et al.
Published: (2020-12-01)